Medical necessity narrative (if requested): For payers that require prior authorization or post-service review, a brief clinical summary explaining why oral supplementation is not appropriate may be required
Product Information Storage Store lyophilized compound at -20C for long-term stability
BPC-157 Peptide: Research Peptide $53.00 10mg of reagent-grade BPC-157
Cytoprotective and Anti-Ulcer Activity As a cytoprotective mediator, BPC-157 demonstrates protective effects on the gastrointestinal mucosal barrier while simultaneously addressing lesions in the liver, brain, and cardiovascular tissue
Persistent, severe, or worsening symptoms should be discussed with a healthcare professional
Minor injection site reactions Temporary nausea at higher doses Slight sleep changes with evening dosing Mild headache during initial days Dizziness or lightheadedness Increased appetite Fatigue during loading phase Minor digestive changes Significant swelling or rash Persistent breathing changes Severe headache or vision changes Any concerning symptoms The peptides mechanism profile suggests certain theoretical concerns worth acknowledging